150 related articles for article (PubMed ID: 1535023)
1. Antiproliferative effect of leuprorelin acetate, alone or combined with tamoxifen or medroxyprogesterone acetate, on human breast cancer cell lines.
Sica G; Iacopino F; Marini L; Robustelli della Cuna G
Clin Ther; 1992; 14 Suppl A():87-96. PubMed ID: 1535023
[TBL] [Abstract][Full Text] [Related]
2. Combined effects of estradiol, leuprorelin, tamoxifen and medroxyprogesterone acetate on cell growth and steroid hormone receptors in breast cancer cells.
Sica G; Iacopino F; Robustelli della Cuna G; Marchetti P; Marini L
J Cancer Res Clin Oncol; 1994; 120(10):605-9. PubMed ID: 7929532
[TBL] [Abstract][Full Text] [Related]
3. Direct antiproliferative effect of triptorelin on human breast cancer cells.
Marini L; Iacopino F; Schinzari G; Robustelli della Cuna FS; Mantovani G; Sica G
Anticancer Res; 1994; 14(5A):1881-5. PubMed ID: 7847821
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibitory effect of LH-RH analogs on human breast cancer cells.
Scambia G; Panici PB; Baiocchi G; Perrone L; Gaggini C; Iacobelli S; Mancuso S
Anticancer Res; 1988; 8(1):187-90. PubMed ID: 2965864
[TBL] [Abstract][Full Text] [Related]
5. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
Sutherland RL; Hall RE; Pang GY; Musgrove EA; Clarke CL
Cancer Res; 1988 Sep; 48(18):5084-91. PubMed ID: 2970295
[TBL] [Abstract][Full Text] [Related]
6. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
7. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells].
Nomura Y; Tashiro H; Takaeko F
Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351
[TBL] [Abstract][Full Text] [Related]
8. Effect of tamoxifen and high-dose medroxyprogesterone acetate (MPA) on cell-mediated immune functions in breast cancer patients.
Mallmann P; Dietrich K; Krebs D
Methods Find Exp Clin Pharmacol; 1990 Dec; 12(10):699-706. PubMed ID: 2151629
[TBL] [Abstract][Full Text] [Related]
9. Effects of tamoxifen, medroxyprogesterone acetate and estradiol on tumor growth and oncogene expression in MCF-7 breast cancer cell line transplanted into nude mice.
Mizukami Y; Tajiri K; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Nakamura S; Matsubara F
Anticancer Res; 1991; 11(3):1333-8. PubMed ID: 1832273
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of lonidamine alone or combined with tamoxifen or medroxyprogesterone acetate in breast cancer cells.
Sica G; Lama G; Iacopino F; Angelucći C; Della Cuna GR; Marchetti P
Anticancer Res; 1991; 11(6):2099-102. PubMed ID: 1776846
[TBL] [Abstract][Full Text] [Related]
11. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture.
Jain PT; Pento JT; Magarian RA
Anticancer Res; 1992; 12(3):585-90. PubMed ID: 1622114
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.
Ouatas T; Halverson D; Steeg PS
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3763-72. PubMed ID: 14506169
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
Gong Y; Anzai Y; Murphy LC; Ballejo G; Holinka CF; Gurpide E; Murphy LJ
Cancer Res; 1991 Oct; 51(20):5476-81. PubMed ID: 1833051
[TBL] [Abstract][Full Text] [Related]
14. [Does interferon-alpha enhance the effect of tamoxifen-medroxyprogesterone acetate and hydroxyflutamide on in vitro tumor cells?].
Werner A; Aichberger A; Krebs D
Zentralbl Gynakol; 1996; 118(11):616-21. PubMed ID: 9082695
[TBL] [Abstract][Full Text] [Related]
15. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
Reddel RR; Murphy LC; Hall RE; Sutherland RL
Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ
Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041
[TBL] [Abstract][Full Text] [Related]
17. Effects of estradiol and tamoxifen on human breast cancer cells in serum-free culture.
Darbre PD; Curtis S; King RJ
Cancer Res; 1984 Jul; 44(7):2790-3. PubMed ID: 6722808
[TBL] [Abstract][Full Text] [Related]
18. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
Liu ZJ; Zhu BT
J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
[TBL] [Abstract][Full Text] [Related]
19. Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines.
Pihie AH; Stanslas J; Din LB
Anticancer Res; 1998; 18(3A):1739-43. PubMed ID: 9673398
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine.
Strobl JS; Kirkwood KL; Lantz TK; Lewine MA; Peterson VA; Worley JF
Cancer Res; 1990 Sep; 50(17):5399-405. PubMed ID: 2386945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
